Rosacea

Ingredients

Show 1 more ingredients
Ingredient	Grade	Effect	Evidence	Studies
Ivermectin	C	Notable Decrease	Fair	2 studies 2629 participants
Metronidazole	C	Slight Decrease	Fair	2 studies 288 participants
Azelaic Acid	C	Slight Decrease	Fair	8 studies 3748 participants
Azelaic Acid + Gluconolactone	D	Slight Decrease	Some	1 study 62 participants
Kinetin	D	Potential Decrease	Some	1 study 17 participants
Quassia Extract	D	Potential Decrease	Some	1 study 27 participants

Products

Product	Grade	Effect	Evidence	Studies
MetroGel	C	Slight Decrease	Fair	1 study 251 participants
Finacea	C	Slight Decrease	Fair	2 studies 313 participants
Finacea + NeoStrata Facial Cleanser + NeoStrata Ultra Moisturizing Face Cream	D	Slight Decrease	Some	1 study 62 participants
Olay Total Effects 7X Visible Anti-Aging Vitamin Complex	D	Potential Decrease	Some	1 study 46 participants
Kinerase	D	Potential Decrease	Some	1 study 17 participants

Treatments

Coming soon.

Skincare treatments can penetrate more deeply into the skin to provide faster, more dramatic and longer-lasting results than topical products, but they are also much more expensive.

Review all of the scientific evidence before spending thousands of dollars on treatments that won't work, or that make your skin worse due to the side effects.

Log in to register your interest in knowing when information on skincare treatments becomes available on Wisderm.com, and get a 20% discount on launch!

2 Studies Found

Intervention	Ivermectin
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	84 days
Participants	1371

Intervention	Ivermectin
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	280 days
Participants	1258

2 Studies Found

Intervention	Metronidazole
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	105 days
Participants	251

Intervention	Metronidazole
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	105 days
Participants	40

8 Studies Found

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	84 days
Participants	67

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	84 days
Participants	116

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	105 days
Participants	251

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	84 days
Participants	664

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	105 days
Participants	40

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	112 days
Participants	401

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	112 days
Participants	961

Intervention	Azelaic Acid
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	280 days
Participants	1258

1 Study Found

Intervention	Azelaic Acid + Gluconolactone
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	84 days
Participants	67

1 Study Found

Intervention	Kinetin
Concern	Rosacea
Subject Type	Human
Trial Design	Open-Label Non-Randomised Uncontrolled
Trial Duration	84 days
Participants	18

1 Study Found

Intervention	Quassia Extract
Concern	Rosacea
Subject Type	Human
Trial Design	Open-Label Non-Randomised Uncontrolled
Trial Duration	45 days
Participants	30

1 Study Found

Intervention	MetroGel
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	105 days
Participants	251

2 Studies Found

Intervention	Finacea
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	84 days
Participants	67

Intervention	Finacea
Concern	Rosacea
Subject Type	Human
Trial Design	Double-Blind Randomised Controlled
Trial Duration	105 days
Participants	251

1 Study Found

Intervention	Finacea + NeoStrata Facial Cleanser + NeoStrata Ultra Moisturizing Face Cream
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	84 days
Participants	67

1 Study Found

Intervention	Olay Total Effects 7X Visible Anti-Aging Vitamin Complex
Concern	Rosacea
Subject Type	Human
Trial Design	Single-Blind Randomised Controlled
Trial Duration	28 days
Participants	50

1 Study Found

Intervention	Kinerase
Concern	Rosacea
Subject Type	Human
Trial Design	Open-Label Non-Randomised Uncontrolled
Trial Duration	84 days
Participants	18

Latest Research

Coming soon.

2 Studies Found

Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials

2 Studies Found

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial

A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea

8 Studies Found

An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients

Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies

A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea

Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials

1 Study Found

An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients

1 Study Found

Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea

1 Study Found

Evaluation of the efficacy and tolerance of a topical gel with 4% quassia extract in the treatment of rosacea

1 Study Found

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial

2 Studies Found

An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial

1 Study Found

An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients

1 Study Found

Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea

1 Study Found

Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea

Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial (2021)

Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial (2021)

A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea (2015)

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials (2014)

Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials (2014)